People · Operator
Named in public records as an officer, director or promoter · active 2014–2025 · Biotechnology, Other, Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp | — | Biotechnology | Series D+ | $614.0M | $8.0B | 2014 |
| higi SH Holdings Inc. | — | Other | Series B | $55.2M | $521.9M | 2018 |
| Navigating Cancer, Inc. | — | Other Technology | Series A | $25.8M | $9.8M | 2019 |
| Vitalchat, Inc. | — | Other Health Care | Seed | $2.0M | $6.8M | 2025 |
Peter Neupert at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter Neupert on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Greeley | 1 | 15 |
| Glen Tullman | 1 | 12 |
| Anna Haghgooie | 1 | 11 |
| David Rubin | 1 | 11 |
| John Collins | 1 | 9 |
| Bruce L.A. Carter | 1 | 5 |
| Chad Robins | 1 | 5 |
| Lee Huntsman | 1 | 5 |
| William Bunker | 1 | 4 |
| Arnold Levine | 1 | 4 |
| John Stuelpnagel | 1 | 3 |
| William Wrigley Jr. | 1 | 3 |
| Tom Unterman | 1 | 3 |
| Michael Raymer | 1 | 3 |
| Chris Kryder | 1 | 2 |
| Jay Holmes | 1 | 2 |
| Harlan Robins | 1 | 2 |
| Craig Weissman | 1 | 2 |
| Michael Graff | 1 | 2 |
| David Travers | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.